Search details
1.
Association of patient, treatment and disease characteristics with patient-reported outcomes: Results of the ECHO Registry.
Haemophilia
; 30(1): 106-115, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38030962
2.
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).
Haemophilia
; 29(3): 743-752, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36811304
3.
Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy.
N Engl J Med
; 377(9): 819-828, 2017 08 31.
Article
in English
| MEDLINE | ID: mdl-28691885
4.
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company.
Haemophilia
; 26(6): 966-974, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-33094894
5.
Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study.
Haemophilia
; 25(2): 205-212, 2019 Mar.
Article
in English
| MEDLINE | ID: mdl-30408835
6.
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.
Haemophilia
; 25(3): 398-407, 2019 May.
Article
in English
| MEDLINE | ID: mdl-31066174
7.
Emicizumab in Hemophilia A.
N Engl J Med
; 382(8): 785, 2020 02 20.
Article
in English
| MEDLINE | ID: mdl-32074440
8.
Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.
Blood
; 126(3): 397-405, 2015 Jul 16.
Article
in English
| MEDLINE | ID: mdl-25911238
9.
Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011.
Blood
; 124(23): 3389-97, 2014 Nov 27.
Article
in English
| MEDLINE | ID: mdl-25339360
10.
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.
Blood
; 122(11): 1954-62, 2013 Sep 12.
Article
in English
| MEDLINE | ID: mdl-23926300
11.
Acquired haemophilia: an easy diagnosis to miss in a patient taking warfarin.
Acute Med
; 14(3): 122-4, 2015.
Article
in English
| MEDLINE | ID: mdl-26767201
12.
The principal results of the International Immune Tolerance Study: a randomized dose comparison.
Blood
; 119(6): 1335-44, 2012 Feb 09.
Article
in English
| MEDLINE | ID: mdl-22101900
13.
Management of pregnancy in type 3 von Willebrand disease with alloantibodies.
Br J Haematol
; 182(3): 440-442, 2018 08.
Article
in English
| MEDLINE | ID: mdl-28699647
14.
Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom.
Blood
; 117(23): 6367-70, 2011 Jun 09.
Article
in English
| MEDLINE | ID: mdl-21471523
15.
Difficult clinical challenges in haemophilia: international experiential perspectives.
Haemophilia
; 18 Suppl 5: 39-45, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22757683
16.
Prothrombin complex concentrate to correct acquired abnormalities of the clotting screen in patients with liver impairment.
Liver Int
; 37(8): 1249-1250, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28241398
17.
A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3.
Blood
; 114(5): 1091-8, 2009 Jul 30.
Article
in English
| MEDLINE | ID: mdl-19372260
18.
General surgery in patients with a bleeding diathesis: how we do it.
World J Surg
; 35(12): 2603-10, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21953125
19.
Mortality in congenital hemophilia A - a systematic literature review.
J Thromb Haemost
; 19 Suppl 1: 6-20, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33331043
20.
Application of a hemophilia mortality framework to the Emicizumab Global Safety Database.
J Thromb Haemost
; 19 Suppl 1: 32-41, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33331041